CLINICAL_TRIALS
trial_result
· 2013-07-30
Clinical Trial Update: The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial) [Phase 3]
Summary
Phase 3 trial comparing canagliflozin to a DPP-4 inhibitor in type 2 diabetes has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2013-07-30